BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28645610)

  • 1. Inhibition of mitochondrial translation effectively sensitizes renal cell carcinoma to chemotherapy.
    Wang B; Ao J; Yu D; Rao T; Ruan Y; Yao X
    Biochem Biophys Res Commun; 2017 Aug; 490(3):767-773. PubMed ID: 28645610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting prenylation augments chemotherapy efficacy in renal cell carcinoma through dual inhibition on mitochondrial respiration and glycolysis.
    Huang J; Yang X; Peng X; Huang W
    Biochem Biophys Res Commun; 2017 Nov; 493(2):921-927. PubMed ID: 28943437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of mitochondrial translation selectively targets osteosarcoma.
    Chen J; Xu X; Fan M
    Biochem Biophys Res Commun; 2019 Jul; 515(1):9-15. PubMed ID: 31118131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia.
    Skrtić M; Sriskanthadevan S; Jhas B; Gebbia M; Wang X; Wang Z; Hurren R; Jitkova Y; Gronda M; Maclean N; Lai CK; Eberhard Y; Bartoszko J; Spagnuolo P; Rutledge AC; Datti A; Ketela T; Moffat J; Robinson BH; Cameron JH; Wrana J; Eaves CJ; Minden MD; Wang JC; Dick JE; Humphries K; Nislow C; Giaever G; Schimmer AD
    Cancer Cell; 2011 Nov; 20(5):674-88. PubMed ID: 22094260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic ivermectin preferentially targets renal cancer through inducing mitochondrial dysfunction and oxidative damage.
    Zhu M; Li Y; Zhou Z
    Biochem Biophys Res Commun; 2017 Oct; 492(3):373-378. PubMed ID: 28847725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxycycline sensitizes renal cell carcinoma to chemotherapy by preferentially inhibiting mitochondrial translation.
    Wang B; Ao J; Li X; Yu W; Yu D; Qiu C
    J Int Med Res; 2021 Oct; 49(10):3000605211044368. PubMed ID: 34644207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting mitochondria by anthelmintic drug atovaquone sensitizes renal cell carcinoma to chemotherapy and immunotherapy.
    Chen D; Sun X; Zhang X; Cao J
    J Biochem Mol Toxicol; 2018 Sep; 32(9):e22195. PubMed ID: 30004155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemosensitization of human renal cell cancer using antisense oligonucleotides targeting the antiapoptotic gene clusterin.
    Zellweger T; Miyake H; July LV; Akbari M; Kiyama S; Gleave ME
    Neoplasia; 2001; 3(4):360-7. PubMed ID: 11571636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrvinium Sensitizes Clear Cell Renal Cell Carcinoma Response to Chemotherapy Via Casein Kinase 1α-Dependent Inhibition of Wnt/β-Catenin.
    Cui L; Zhao J; Liu J
    Am J Med Sci; 2018 Mar; 355(3):274-280. PubMed ID: 29549930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mTOR activation is critical for betulin treatment in renal cell carcinoma cells.
    Cheng W; Ji S; Zhang H; Han Z; Liu Q; Wang J; Ping H
    Biochem Biophys Res Commun; 2017 Jan; 482(4):1030-1036. PubMed ID: 27908730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic tigecycline enhances cisplatin activity against human hepatocellular carcinoma through inducing mitochondrial dysfunction and oxidative damage.
    Tan J; Song M; Zhou M; Hu Y
    Biochem Biophys Res Commun; 2017 Jan; 483(1):17-23. PubMed ID: 28069382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of mitochondrial translation as a therapeutic strategy for human ovarian cancer to overcome chemoresistance.
    Hu B; Guo Y
    Biochem Biophys Res Commun; 2019 Feb; 509(2):373-378. PubMed ID: 30591219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effects of antibiotic drug mefloquine against cervical cancer through impairing mitochondrial function and inhibiting mTOR pathway.
    Li H; Jiao S; Li X; Banu H; Hamal S; Wang X
    Can J Physiol Pharmacol; 2017 Jan; 95(1):43-50. PubMed ID: 27831748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tigecycline-induced inhibition of mitochondrial DNA translation may cause lethal mitochondrial dysfunction in humans.
    Vandecasteele SJ; Seneca S; Smet J; Reynders M; De Ceulaer J; Vanlander AV; van Coster R
    Clin Microbiol Infect; 2018 Apr; 24(4):431.e1-431.e3. PubMed ID: 28870729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of STAT1 sensitizes renal cell carcinoma cells to radiotherapy and chemotherapy.
    Zhu H; Wang Z; Xu Q; Zhang Y; Zhai Y; Bai J; Liu M; Hui Z; Xu N
    Cancer Biol Ther; 2012 Apr; 13(6):401-7. PubMed ID: 22262126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docetaxel enhances apoptosis and G2/M cell cycle arrest by suppressing mitogen-activated protein kinase signaling in human renal clear cell carcinoma.
    Han TD; Shang DH; Tian Y
    Genet Mol Res; 2016 Feb; 15(1):. PubMed ID: 26909952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein Kinase RNA-Like Endoplasmic Reticulum Kinase-Mediated Bcl-2 Protein Phosphorylation Contributes to Evodiamine-Induced Apoptosis of Human Renal Cell Carcinoma Cells.
    Wu WS; Chien CC; Chen YC; Chiu WT
    PLoS One; 2016; 11(8):e0160484. PubMed ID: 27483435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of mitochondrial respiration with auraptene inhibits the progression of renal cell carcinoma: involvement of HIF-1α degradation.
    Jang Y; Han J; Kim SJ; Kim J; Lee MJ; Jeong S; Ryu MJ; Seo KS; Choi SY; Shong M; Lim K; Heo JY; Kweon GR
    Oncotarget; 2015 Nov; 6(35):38127-38. PubMed ID: 26474388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial translation: elongation factor tu is essential in fission yeast and depends on an exchange factor conserved in humans but not in budding yeast.
    Chiron S; Suleau A; Bonnefoy N
    Genetics; 2005 Apr; 169(4):1891-901. PubMed ID: 15695360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel/Taxol sensitivity in human renal cell carcinoma is not determined by the p53 status.
    Reinecke P; Kalinski T; Mahotka C; Schmitz M; Déjosez M; Gabbert HE; Gerharz CD
    Cancer Lett; 2005 May; 222(2):165-71. PubMed ID: 15863265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.